Cargando…
Case presentation: Very early combined first-line immunotherapy and surgery in tumor-associated anti N-methyl-d-aspartate (NMDA) receptor encephalitis associated with improved outcome
INTRODUCTION: Anti N-methyl-d-aspartate receptor (anti-NMDA-R) encephalitis is a potentially reversible cause of psychosis. Nearly all patients (>95.5%) quickly develop additional neurological symptoms, and only about 50 percent fully recover, often with latency. At symptom onset, patients common...
Autores principales: | Witzel, S., Zeiss, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434441/ http://dx.doi.org/10.1192/j.eurpsy.2023.786 |
Ejemplares similares
-
Anti N‐Methyl‐D‐Aspartate (NMDA) receptor encephalitis: from psychosis to cognitive impairment
por: Vahabi, Zahra, et al.
Publicado: (2021) -
Case Report: Cotard's Syndrome in Anti-N-methyl D-aspartate (NMDA) Receptor (Anti-NMDAR) Encephalitis
por: Taib, Nur Iwana Abdul, et al.
Publicado: (2022) -
The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis
por: Olaleye, Kehinde T, et al.
Publicado: (2021) -
Anti-N-methyl-D-aspartate Receptor Encephalitis
por: Tanquary, Gregory, et al.
Publicado: (2019) -
Factors Affecting the Response to First-Line Treatments in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis
por: Zhang, Xiaoting, et al.
Publicado: (2019)